“Re: Should systematic prostatic biopsies be discontinued?” https://www.nature.com/articles/s41391-025-01027-x

KBTBD11 loss promotes AKT hyperactivation and therapeutic vulnerability in prostate cancer https://www.nature.com/articles/s41388-025-03576-w

Using patient-reported outcomes from the PROCLAIM trial to assess the impact of universal germline genetic testing for prostate cancer patients https://www.nature.com/articles/s41391-025-01013-3

Addition of a surgery-specific module to a perioperative, telemedicine program for improving functional outcomes after radical prostatectomy: a prospective, multicenter, non-randomized study https://www.nature.com/articles/s41391-025-01026-y

Aging-associated ZNF573 methylation regulates RNF19B-PIK3CA ubiquitination to promote prostate cancer https://www.nature.com/articles/s41388-025-03579-7